title: Weighing up the risks and benefits of smoking cessation therapies.
authors.forename: Phillip
authors.initials: P
authors.lastname: Bland
mesh_terms: D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects*; D001552:Benzazepines / Q000009:adverse effects*; D016642:Bupropion / Q000009:adverse effects*; D006801:Humans; D018722:Nicotinic Agonists / Q000009:adverse effects*; D011810:Quinoxalines / Q000009:adverse effects*; D018570:Risk Assessment; D016540:Smoking Cessation / Q000523:psychology*; D061485:Tobacco Use Cessation Devices / Q000009:adverse effects*; D000068580:Varenicline
chemical_list: D018687:Antidepressive Agents, Second-Generation; D001552:Benzazepines; D018722:Nicotinic Agonists; D011810:Quinoxalines; D016642:Bupropion; D000068580:Varenicline